These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 23104656
1. Risk factors for maternal mortality in eclampsia: analysis of 167 eclamptic cases. Sak ME, Evsen MS, Soydinc HE, Turgut A, Ozler A, Sak S, Celik Y, Gul T. Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1399-403. PubMed ID: 23104656 [Abstract] [Full Text] [Related]
2. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome? Guzel AI, Kuyumcuoglu U, Celik Y. Arch Gynecol Obstet; 2011 Jun; 283(6):1227-32. PubMed ID: 20526778 [Abstract] [Full Text] [Related]
3. [Clinical outcomes and characteristics of concurrent eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome]. DI XD, Chen DJ, Liu HS, Kuang JL, Huang DJ. Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):740-4. PubMed ID: 21176553 [Abstract] [Full Text] [Related]
4. Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia. Uckan K, Sahin HG. J Obstet Gynaecol Res; 2018 Mar; 44(3):440-447. PubMed ID: 29345041 [Abstract] [Full Text] [Related]
5. Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital. Gedik E, Yücel N, Sahin T, Koca E, Colak YZ, Togal T. Hypertens Pregnancy; 2017 Feb; 36(1):21-29. PubMed ID: 27599183 [Abstract] [Full Text] [Related]
6. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Acta Obstet Gynecol Scand; 2007 Feb; 86(6):648-51. PubMed ID: 17520393 [Abstract] [Full Text] [Related]
7. The evaluation of maternal parameters at diagnosis may predict HELLP syndrome severity. Carpani G, Bozzo M, Ferrazzi E, D'Amato B, Pizzotti D, Radaelli T, Moroni G, Pardi G. J Matern Fetal Neonatal Med; 2003 Mar; 13(3):147-51. PubMed ID: 12820835 [Abstract] [Full Text] [Related]
8. [Risk factors analysis of reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia gravida]. Fang XB, Chen DJ, He F, Su CH, Ren LW, Chen J, Liang YL. Zhonghua Fu Chan Ke Za Zhi; 2017 Jan 25; 52(1):40-46. PubMed ID: 28190314 [Abstract] [Full Text] [Related]
9. [Maternal morbidity and perinatal mortality in HELLP syndrome. Multicentric studies in intensive care units in Buenos Aires area]. Malvino E, Muñoz M, Ceccotti C, Janello G, Mc Loughlin D, Pawlak A, Desmery P, Lopez Gaston O. Medicina (B Aires); 2005 Jan 25; 65(1):17-23. PubMed ID: 15830788 [Abstract] [Full Text] [Related]
10. HELLP syndrome: the experience at Ile-Ife, Nigeria. Makinde ON, Adegoke OA, Adediran IA, Ndububa DA, Adeyemi AB, Owolabi AT, Kuti O, Orji EO, Salawu L. J Obstet Gynaecol; 2009 Apr 25; 29(3):195-9. PubMed ID: 19358023 [Abstract] [Full Text] [Related]
11. Comparison of referral and non-referral hypertensive disorders during pregnancy: an analysis of 271 consecutive cases at a tertiary hospital. Liu CM, Chang SD, Cheng PJ. Chang Gung Med J; 2005 May 25; 28(5):326-34. PubMed ID: 16086547 [Abstract] [Full Text] [Related]
12. [Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care]. Basavilvazo Rodríguez A, Pacheco Pérez C, Lemus Rocha R, Martínez Pérez JM, Martínez Martínez A, Hernández-Valencia M. Ginecol Obstet Mex; 2003 Aug 25; 71():379-86. PubMed ID: 14619691 [Abstract] [Full Text] [Related]
14. The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome. Ozer A, Kanat-Pektas M, Ozer S, Tapisiz OL, Zulfikaroglu EE, Danisman N. Arch Gynecol Obstet; 2009 Jul 25; 280(1):65-70. PubMed ID: 19089438 [Abstract] [Full Text] [Related]
15. Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti. Small MJ, Kershaw T, Frederic R, Blanc C, Neale D, Copel J, Williams KP. J Matern Fetal Neonatal Med; 2005 Nov 25; 18(5):343-8. PubMed ID: 16390796 [Abstract] [Full Text] [Related]
16. [A report of fourteen cases with hemolysis, elevated liver enzymes and low platelet count syndrome]. Zeng F, Chen D. Zhonghua Fu Chan Ke Za Zhi; 2002 Sep 25; 37(9):526-8. PubMed ID: 12411011 [Abstract] [Full Text] [Related]
17. Risk factors of maternal death in Mexico. Romero-Gutiérrez G, Espitia-Vera A, Ponce-Ponce de León AL, Huerta-Vargas LF. Birth; 2007 Mar 25; 34(1):21-5. PubMed ID: 17324174 [Abstract] [Full Text] [Related]
18. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Demir SC, Evruke C, Ozgunen FT, Urunsak IF, Candan E, Kadayifci O. Saudi Med J; 2006 Jul 25; 27(7):1015-8. PubMed ID: 16830022 [Abstract] [Full Text] [Related]
19. Maternal and fetal outcome in eclamptic patients in Benin City, Nigeria. Onuh SO, Aisien AO. J Obstet Gynaecol; 2004 Oct 25; 24(7):765-8. PubMed ID: 15763783 [Abstract] [Full Text] [Related]
20. Pregnancy outcome in eclamptics at the University of Abuja Teaching Hospital, Gwagwalada, Abuja: a 3 year review. Agida ET, Adeka BI, Jibril KA. Niger J Clin Pract; 2010 Dec 25; 13(4):394-8. PubMed ID: 21220852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]